7 December, 2016
New Delhi, India
Manica Balasegaram, Director and Jean Pierre Paccaud, Director of Business Development & Corporate Strategy at GARDP, and Suman RIjal, Head of the DNDi office in India, presented at the event.
7 December, 2016
1 September, 2016
Cape Town, South Africa
This one day gathering of 45 participants from 11 African countries aimed at advancing a collective understanding of and potential to address the most pressing antimicrobial-resistance (AMR)-related medical needs, research and development gaps, and collaboration opportunities in South Africa and other sub-Saharan countries.
2-3 August, 2016
A joint WHO-DNDi Global Antibiotic Research and Development Partnership (GARDP) event which was organized to review and evaluate an important NeoAMR proposal and to form a consensus on the way forward.
27-28 June, 2016
This one day meeting with 26 participants from all around the world reviewed and evaluated the needs, progress and development of new and effective treatment options for gonorrhea.
24 May, 2016
This event launched the Global Antibiotic R&D Partnership (GARDP), a joint WHO/DNDi initiative incubated by DNDi in support of the Global Action Plan for Antimicrobial Resistance. GARDP aims to develop new antibiotic treatments, promote responsible use, and ensure access for all.
29 February, 2016
Institut Pasteur, Paris, France
The aim of this initial scientific consultation was to help GARD evolve from the initial scientific strategy articulated in the initial and revised GARD concept notes, determine priority areas and short- to medium-term projects to be launched within one year. Longer-term (upstream) projects will also be considered as GARD builds its R&D pipeline.